New peri-op approach accurately IDs melanoma in nail matrix

New peri-Op approach accurately IDs melanoma in nail matrix
Intraoperative reflectance confocal microscopy can be used to diagnose melanonychia striata in the nail matrix, according to a study published online June 7 in the British Journal of Dermatology.

(HealthDay) -- Intraoperative reflectance confocal microscopy (RCM) can be used to diagnose melanonychia striata in the nail matrix, according to a study published online June 7 in the British Journal of Dermatology.

Sébastien Debarbieux, M.D., of the Centre Hospitalier Lyon Sud in Pierre Bénite, France, and colleagues assessed the feasibility of intraoperative of melanonychia striata in a series of nine patients who underwent a matricial biopsy for an acquired melanonychia (one benign lentigo, eight melanomas). RCM examination was performed in vivo and/or ex vivo.

The researchers found that confocal and histopathological features correlated well. Confocal features were used for unequivocal intraoperative diagnosis of seven of the cases, and RCM correctly classified the lentigo as benign. RCM did not provide a definite classification for the last lesion, which corresponded histopathologically to an early melanoma.

"Intraoperative RCM examination of the nail matrix is an efficient diagnostic approach of melanonychia striata that permits an extemporaneous diagnosis of malignancy and therefore a one-step surgical treatment of in situ or minimally invasive melanoma, reducing dramatically the duration of postoperative disability," the authors write.

More information: Abstract
Full Text (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

Melanomas may appear noticeably different than other moles

Jan 21, 2008

A preliminary study suggests that melanomas have a different appearance than other irregular skin moles (i.e., are “ugly ducklings”), according to a report in the January issue of Archives of Dermatology, one of the JAMA/Archives ...

Recommended for you

XenOPAT, mouse models for personalized cancer treatment

14 hours ago

On September 8th, the company XenOPAT SL, a spin-off of the Institute of Biomedical Research (IDIBELL) and the Catalan Institute of Oncology (ICO) was established with the aim of bringing the company the latest scientific ...

User comments